Skip to main content
CATX logo

Perspective Therapeutics, Inc.

CATXNYSEAMERICANHealthcareMedical Devices

$1.21Today:- (-)1Y −21.53%

As of Oct 26, 2026 close

Market cap
$145.99M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.96$6.16
Volume (live)
-
Avg. volume (3M)
2.57M

Perspective Therapeutics, Inc. (CATX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Perspective Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 16 professional research analysts

Consensus Rating

Buy
Based on 16 unique analysts
(23 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$12.00
+891.74% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CATX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

David Lebowitz
BMO Capital
BuyMaintains
$11.00
Alec Stranahan
BofA Securities
HoldMaintains
$5.00
Leonid Timashev
RBC Capital
BuyMaintains
$14.00
Unknown Analyst
Wedbush
BuyMaintains
$11.00
Gregory Renza
Truist
BuyMaintains
$11.00
David Dai
UBS
BuyMaintains
$8.00
David Dai
UBS
BuyMaintains
$8.00
David Nierengarten
Wedbush
BuyMaintains
$11.00
Andy Hsieh
William Blair
BuyInitiates
-
Gregory Renza
Truist
BuyMaintains
-
David Lebowitz
BMO Capital
BuyMaintains
$11.00
David Lebowitz
BMO Capital
BuyMaintains
$11.00
Unknown Analyst
BMO Capital
BuyInitiates
$11.00
Justin Walsh
JonesTrading
BuyReiterates
$18.00
Alec Stranahan
BofA Securities
HoldReiterates
$6.00 → $5.00
Oliver McCammon
LifeSci Capital
BuyMaintains
$15.00
Unknown Analyst
Wedbush
BuyMaintains
$11.00
Biren Amin
Piper Sandler
BuyInitiates Coverage
$16.00 → $14.00
Jeet Mukherjee
BTIG
BuyMaintains
$14.00
Jeff Jones
Oppenheimer
BuyReiterates
$13.00
Leonid Timashev
RBC Capital
BuyMaintains
$14.00
Ekta Bagri
Zacks Equity Research
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 20, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CATX?

The analyst consensus rating for CATX is Buy, based on the latest ratings from 16 analysts over the last 90 days.

What is the average price target for CATX?

The average 12-month price target for CATX is $12.00, representing an upside of 891.7% from the Oct 26, 2026 close of $1.21.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.